M. Baysal Et Al. , "Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review," Expert Review of Hematology , vol.16, no.2, pp.131-140, 2023
Baysal, M. Et Al. 2023. Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review. Expert Review of Hematology , vol.16, no.2 , 131-140.
Baysal, M., Bayrak, M., & EŞKAZAN, A. E., (2023). Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review. Expert Review of Hematology , vol.16, no.2, 131-140.
Baysal, Mehmet, Meltem Bayrak, And AHMET EMRE EŞKAZAN. "Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review," Expert Review of Hematology , vol.16, no.2, 131-140, 2023
Baysal, Mehmet Et Al. "Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review." Expert Review of Hematology , vol.16, no.2, pp.131-140, 2023
Baysal, M. Bayrak, M. And EŞKAZAN, A. E. (2023) . "Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review." Expert Review of Hematology , vol.16, no.2, pp.131-140.
@article{article, author={Mehmet Baysal Et Al. }, title={Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review}, journal={Expert Review of Hematology}, year=2023, pages={131-140} }